Abstract
Background: Cases of malignant ovarian tumors consisting of Clear Cell Carcinoma (CCC) and Yolk Sac Tumor (YST) are decidedly rare. Case: We herein report the case of a 58-year-old woman with an ovarian tumor, of which ap- proximately 70 percent was composed of CCC and 30 percent YST. The plan was to utilize a chemotherapeutic regimen of 4 cycles of Bleomycin, Etoposide, Cisplatin (BEP) followed by 4 cycles of Carboplatin/Paclitaxel. Conclusion: No previous cases with an identical combination of CCC and YST have been found in the literature. Because of its rarity, deciding on optimal therapy is challenging.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.